At 68%, New Hampshire has the second highest rate of refusal for Breathalyzer tests in the United States, according to state officials.
A woman deemed by an airline to be too intoxicated to fly was arrested by officers at an airport, according to New Haven ...
A politically charged interaction at a Smoothie King has gone viral, sparking the discussion of what rights employers, ...
KAUAI, Hawaii (KHON2) — The Kauai refuse transfer facilities and the Kekaha Landfill have updated their current service status. As of 6:30 a.m. on Monday, Feb. 23, the Hanalei refuse transfer station ...
Add DMNews to your Google News feed. The math does not add up in the way most people expect. A 36-year-old woman in Singapore was sentenced to jail — not for stealing, not for assault causing grievous ...
Kimora Lee Simmons is reportedly refusing to vacate a lavish $25 million mansion her estranged husband purchased with stolen funds. Kimora Lee Simmons is being put on the radar over a lavish $25 ...
In this week’s edition of InnovationRx, we look at the FDA’s refusal to review Moderna’s flu vaccine, the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 ...
The Food and Drug Administration has refused to review Moderna’s application for an mRNA flu vaccine, the company revealed Tuesday. While the move came as a surprise to the high-profile vaccine maker, ...
Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. The House Judiciary Committee’s hearing on oversight of the Justice Department ...
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F.